RADIOIMMUNOSCINTIGRAPHY WITH IN-111 LABELED MONOCLONAL-ANTIBODY FRAGMENTS (F(AB')2 BW 431/31) AGAINST CEA - RADIOLABELLING, ANTIBODY KINETICS AND DISTRIBUTION, FINDINGS IN TUMOR AND NON-TUMOR PATIENTS

被引:18
|
作者
BARES, R
FASS, J
TRUONG, S
BUELL, U
SCHUMPELICK, V
机构
关键词
D O I
10.1097/00006231-198909000-00002
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:627 / 641
页数:15
相关论文
共 45 条
  • [21] MULTICENTER IMMUNOSCINTIGRAPHIC STUDY USING INDIUM-111-LABELED CEA-SPECIFIC AND/OR 19-9 MONOCLONAL-ANTIBODY F(AB')2 FRAGMENTS
    CHETANNEAU, A
    BAUM, RP
    LEHUR, PA
    LIEHN, JC
    PERKINS, AC
    BARES, R
    BOURGUET, P
    HERRY, JY
    SACCAVINI, JC
    CHATAL, JF
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1990, 17 (05): : 223 - 229
  • [22] BLOOD AND TISSUE KINETICS OF RADIOLABELED ANTI-CEA MONOCLONAL-ANTIBODY AND F(AB)2 AND FAB FRAGMENTS IN NUDE-MICE WITH HUMAN-TUMOR XENOGRAFTS - IMPLICATIONS FOR TUMOR IMAGING AND RADIOIMMUNOTHERAPY
    PIMM, MV
    ANDREW, SM
    BALDWIN, RW
    NUCLEAR MEDICINE COMMUNICATIONS, 1989, 10 (08) : 585 - 593
  • [23] A COMPARISON OF IODINE AND INDIUM LABELED ANTI CEA INTACT ANTIBODY, F(AB)2 AND FAB FRAGMENTS BY IMAGING TUMOR XENOGRAFTS
    ANDREW, SM
    PERKINS, AC
    PIMM, MV
    BALDWIN, RW
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1988, 13 (11): : 598 - 604
  • [24] COMPARISON OF IN-111 LABELED FAB AND WHOLE-111 IN ANTI-CEA MONOCLONAL-ANTIBODY (MOAB) IN NORMAL MOUSE - HUMAN-COLON TUMOR-MODELS
    HAGAN, PL
    HALPERN, SE
    CHEN, A
    FRINCKE, JM
    BARTHOLOMEW, RM
    DAVID, GS
    CARLO, DJ
    JOURNAL OF NUCLEAR MEDICINE, 1983, 24 (05) : P77 - P77
  • [25] RADIOIMMUNOIMAGING OF HUMAN BREAST-CARCINOMA XENOGRAFTS IN NUDE-MOUSE MODEL WITH IN-111 LABELED NEW MONOCLONAL-ANTIBODY EBA-1 AND F(AB')2 FRAGMENTS
    YEMUL, S
    LEON, JA
    POZNIAKOFF, T
    ESSER, PD
    ESTABROOK, A
    NUCLEAR MEDICINE AND BIOLOGY, 1993, 20 (03): : 325 - 335
  • [26] IMMUNOSCINTIGRAPHY OF ADENOCARCINOMAS BY MEANS OF IN-111-LABELLED F(AB')2 FRAGMENTS OF ANTI-CEA MONOCLONAL-ANTIBODY F023C5
    RIVA, P
    PAGANELLI, G
    CALLEGARO, L
    BARTOLI, MG
    TURCI, D
    BENINI, S
    DELEIDE, G
    SCASSELLATI, GA
    VIALE, G
    SICCARDI, AG
    NUCLEAR MEDICINE COMMUNICATIONS, 1988, 9 (08) : 577 - 589
  • [27] MONOCLONAL-ANTIBODY AND F(AB')2 FRAGMENT DELIVERY TO TUMOR IN PATIENTS WITH GLIOMA - COMPARISON OF INTRACAROTID AND INTRAVENOUS ADMINISTRATION
    ZALUTSKY, MR
    MOSELEY, RP
    BENJAMIN, JC
    COLAPINTO, EV
    FULLER, GN
    COAKHAM, HP
    BIGNER, DD
    CANCER RESEARCH, 1990, 50 (13) : 4105 - 4110
  • [28] ANTIBODY GUIDED TUMOR-DETECTION USING I-131 LABELED F(AB')2 FRAGMENTS OF AN ANTI-CEA MOAB
    RIVA, P
    PAGANELLI, G
    CACCIAGUERRA, G
    GENTILI, G
    MARRI, L
    TISON, V
    MARANGOLO, M
    AMADORI, D
    BRITISH JOURNAL OF CANCER, 1985, 52 (04) : 649 - 649
  • [29] UPTAKE OF A MONOCLONAL-ANTIBODY AGAINST CEA (TUMAK 431/31) IN A HUMAN-COLON TUMOR (CO-112) XENOGRAFTED IN THE NUDE-MOUSE - DEPENDENCE ON TUMOR SIZE AND INJECTED DOSE
    DUEWELL, S
    HORST, W
    WESTERA, G
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1986, 23 (02) : 101 - 106
  • [30] KINETICS AND TISSUE DISTRIBUTION OF THE RADIOLABELED CHIMERIC MONOCLONAL-ANTIBODY MOV18 IGG AND F(AB')(2) FRAGMENTS IN OVARIAN-CARCINOMA PATIENTS
    BUIST, MR
    KENEMANS, P
    DENHOLLANDER, W
    VERMORKEN, JB
    MOLTHOFF, CJM
    BURGER, CW
    HELMERHORST, TJM
    BAAK, JPA
    ROOS, JC
    CANCER RESEARCH, 1993, 53 (22) : 5413 - 5418